Sage Journals: Discover world-class research

Abstract

Purpose:

Intensive care unit-acquired weakness (ICUAW) can manifest as muscle weakness or neuropathy-like symptoms, with diagnosis remaining a challenge. Uncertainties surround the long-term cause and sequelae. Therefore, the purpose was to assess incidence, time course and long-term influence on quality of life (QoL) of symptoms in ICU survivors

Methods:

After ethical approval and registration (www.drks.de: DRKS00011593), in a single-center cohort study all patients admitted to the ICU in 2007–2017 in a German university hospital were screened. Out of 1,860 patients (≥7d ICU care including ventilation support for ≥72 h, at least 6mo-10y after ICU) 636 were deceased, 912 survivors were contacted.

Results:

149 former patients (age: 63.5 ± 13.1y; males: 73%; duration in ICU: 20.8 ± 15.7d; duration of ventilation: 16.5 ± 13.7 h; time post-ICU: 4.4 ± 2.7y, 5-10y: 43%) consented to be interviewed concerning occurrence, duration, recovery and consequences of ICUAW-associated muscle weakness or neuropathy-like symptoms after ICU. In 75% at least 1 persistent or previous symmetrical symptom was reported (myopathy-like muscle weakness: 43%; neuropathy-like symptoms: 13%; both: 44%) and rated as incidence of ICUAW. However, only 18% of participants had received an ICUAW diagnosis by their physicians, although 62% had persistent symptoms up to 10y after ICU (5-10y: 46%). Only 37% of participants reported a complete recovery of symptoms, significantly associated with an initially low number of symptoms after ICU (p < 0.0001), myopathy-like symptoms (p = 0.024), and younger age at the time of ICU admission (55.7 ± 13.1 vs. 62.6 ± 10.6y, p < 0.001). ICUAW still impaired the QoL at the time of the interview in 74% of affected survivors, with 30% reporting severe impairment.

Conclusion:

ICUAW symptoms were disturbingly common in the majority of long-term survivors, indicating that symptoms persist up to 10y and frequently impair QoL. However, only a small number of patients had been diagnosed with ICUAW. Trial registry: Deutsches Register Klinischer Studien (DRKS), https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00011593, registration number: DRKS00011593.

Keywords

intensive care unit-acquired weakness ICUAW pain muscle weakness long-term survivors

Get full access to this article

View all access options for this article.

References

Herridge

. Legacy of intensive care unit-acquired weakness. Crit Care Med. 2009;37(10 suppl):S457–461.

Bednarik

Vondracek

Dusek

Moravcova

Cundrle

. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252(3):343–351.

De Jonghe

Bastuji-Garin

Sharshar

Outin

Brochard

. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30(6):1117–1121.

Witt

. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99(1):176–184.

Appleton

Kinsella

. Intensive care unit-acquired weakness. BJA Educ. 2012;12:62–66.

Pati

Goodfellow

Iyadurai

Hilton-Jones

. Approach to critical illness polyneuropathy and myopathy. Postgrad Med J. 2008;84(993):354–360.

van der Schaaf

Beelen

de Vos

. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil. 2004;26(20):1189–1197.

Latronico

Shehu

Seghelini

. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. 2005;11(4):381–390.

Bednarik

Lukas

Vondracek

. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 2003;29(9):1505–1514.

10.

Kemp

Laycock

Costello

Brett

. Chronic pain in critical care survivors: a narrative review. Br J Anaesth. 2019;123(2):e372–e384.

11.

Appleton

Kinsella

Quasim

. The incidence of intensive care unit-acquired weakness syndromes: a systematic review. J Intensive Care Soc. 2015;16(2):126–136.

12.

Confer

Wolcott

Hayes

. Critical illness polyneuromyopathy. Am J Health-Syst Pharm. 2012;69(14):1199–1205.

13.

Zink

Kollmar

Schwab

. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol. 2009;5(7):372–379.

14.

Young

Hammond

. A stronger approach to weakness in the intensive care unit. Crit Care Lond Engl. 2004;8(6):416–418.

15.

Guarneri

Bertolini

Latronico

. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian Multicentre CRIMYNE Study. J Neurol Neurosurg Psychiatry. 2008;79(7):838–841.

16.

Herridge

. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(8):683–693.

17.

Herridge

Tansey

Matté

, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–1304.

18.

Fletcher

Kennedy

Ghosh

, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31(4):1012–1016. doi:10.1097/01.CCM.0000053651.38421.D9

19.

Cheung

Tansey

Tomlinson

, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;174(5):538–544.

20.

von Elm

Altman

Egger

, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet Lond Engl. 2007;370(9596):1453–1457.

21.

Geissner

. The Pain Perception Scale—a differentiated and change-sensitive scale for assessing chronic and acute pain [in German]. Rehabil. 1995;34(4):XXXV–XLIII.

22.

Hoitsma

De Vries

Drent

. The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med. 2011;105(1):95–100.

23.

Freynhagen

Baron

Gockel

Tölle

. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–1920.

24.

Schweickert

Hall

. ICU-acquired weakness. Chest. 2007;131:1541–1549.

25.

Benz

. Die Festsetzung des Gesamt-GdB (Schwerbehindertenrecht) und der Gesamt-MdE (gesetzliche Unfallversicherung). Sozialgerichtsbarkeit. 2009;S. 353.

26.

Pérez-Silva

Araujo-Voces

Quesada

nVenn: generalized, quasi-proportional Venn and Euler diagrams. Bioinformatics. 2018; 34(13):2322–2324.

27.

, eds. High-Dimensional Data Analysis in Cancer Research [Internet]. Springer-Verlag. Published 2009. Accessed August 1, 2020. https://www.springer.com/de/book/9780387697635

28.

Coakley

Nagendran

Yarwood

Honavar

Hinds

. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med. 1998;24(8):801–807.

29.

Van den Berghe

Schoonheydt

Becx

Bruyninckx

Wouters

. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348–1353.

30.

Hermans

Wilmer

Meersseman

, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007;175(5):480–489.

31.

de Letter

Schmitz

Visser

, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29(12):2281–2286.

32.

Coronel

Mercatello

Couturier

, et al. Polyneuropathy: potential cause of difficult weaning. Crit Care Med. 1990;18(5):486–489.

33.

Semmler

Okulla

Kaiser

Seifert

Heneka

. Long-term neuromuscular sequelae of critical illness. J Neurol. 2013;260(1):151–157.

34.

Hermans

Van den Berghe

. Clinical review: intensive care unit acquired weakness. Crit Care Lond Engl. 2015;19(1):274.

35.

De Jonghe

Sharshar

Lefaucheur

J-P

, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859–2867.

36.

Latronico

Guarneri

. Critical illness myopathy and neuropathy. Minerva Anestesiol. 2008;74(6):319–323.

37.

Latronico

Herridge

Hopkins

, et al. The ICM research agenda on intensive care unit-acquired weakness. Intensive Care Med. 2017;43(9):1270–1281.

38.

Van Aerde

Meersseman

Debaveye

, et al. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020;46(6):1184–1193. Accessed January 27, 2020. doi:10.1007/s00134-020-05927-5

39.

Vanhorebeek

Latronico

Van den Berghe

. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–653.

40.

Timmers

Verhofstad

MHJ

Moons

KGM

van Beeck

Leenen

LPH

. Long-term quality of life after surgical intensive care admission. Arch Surg Chic Ill 1960. 2011;146(4):412–418.

41.

De Jonghe

Cook

Sharshar

Lefaucheur

Carlet

Outin

. Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d’Etude sur les Neuromyopathies En Reanimation. Intensive Care Med. 1998;24(12):1242–1250. doi:10.1007/s001340050757

42.

Garnacho-Montero

. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288–1296.

43.

Garnacho-Montero

Amaya-Villar

Garcia-Garmendia

Madrazo-Osuna

Ortiz-Leyba

. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005;33(2):349–354.

44.

Leijten

de Weerd

Poortvliet

de Weerd

. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274(15):1221–1225.

45.

Zochodne

DW.

Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 1987;110(pt 4):819–841.

46.

Kelmenson

Held

Allen

, et al. Outcomes of intensive care unit patients with a discharge diagnosis of critical illness polyneuromyopathy: a propensity matched analysis. Crit Care Med. 2017;45(12):2055–2060.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

1.40 MB

0.01 MB

0.04 MB

0.02 MB

15.91 MB

Incidence,Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors

Abstract

Purpose:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material